- Home
- RCMT vs MIST Comparison
RCMT vs MIST Comparison
Compare RCMT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- MIST
- Stock Information
- Founded
- RCMT 1971
- MIST 2003
- Country
- RCMT United States
- MIST Canada
- Employees
- RCMT N/A
- MIST N/A
- Industry
- RCMT Professional Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- RCMT Consumer Discretionary
- MIST Health Care
- Exchange
- RCMT Nasdaq
- MIST Nasdaq
- Market Cap
- RCMT 200.2M
- MIST 163.2M
- IPO Year
- RCMT N/A
- MIST N/A
- Fundamental
- Price
- RCMT $19.11
- MIST $2.00
- Analyst Decision
- RCMT Strong Buy
- MIST Strong Buy
- Analyst Count
- RCMT 2
- MIST 3
- Target Price
- RCMT $33.50
- MIST $6.33
- AVG Volume (30 Days)
- RCMT 35.1K
- MIST 1.7M
- Earning Date
- RCMT 11-05-2025
- MIST 11-12-2025
- Dividend Yield
- RCMT N/A
- MIST N/A
- EPS Growth
- RCMT N/A
- MIST N/A
- EPS
- RCMT 1.71
- MIST N/A
- Revenue
- RCMT $309,840,000.00
- MIST N/A
- Revenue This Year
- RCMT $15.03
- MIST N/A
- Revenue Next Year
- RCMT $7.49
- MIST N/A
- P/E Ratio
- RCMT $11.38
- MIST N/A
- Revenue Growth
- RCMT 13.70
- MIST N/A
- 52 Week Low
- RCMT $13.18
- MIST $0.63
- 52 Week High
- RCMT $28.27
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- RCMT 27.22
- MIST 57.15
- Support Level
- RCMT $18.93
- MIST $1.85
- Resistance Level
- RCMT $23.36
- MIST $1.99
- Average True Range (ATR)
- RCMT 0.86
- MIST 0.12
- MACD
- RCMT -0.30
- MIST 0.01
- Stochastic Oscillator
- RCMT 18.35
- MIST 82.14
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).